Japanese Real-World Data Reproduce Trial Survival Signals in Lung Cancer
A Japanese historical cohort study reconstructed progression-free survival of 3.5 months in 75 atezolizumab-treated lung cancer patients from unstructured electronic ...
A Japanese historical cohort study reconstructed progression-free survival of 3.5 months in 75 atezolizumab-treated lung cancer patients from unstructured electronic ...
A retrospective US cohort of 2,694 pancreatic cancer patients found MTAP deletion in 30.5 percent of tumors and consistently lower ...
A prospective study of 48 patients links dual-tracer FDG and FAPI-04 PET/CT measurements to aggressive pathological features and survival in ...
A calibrated flow cytometry protocol detects CD45-negative EpCAM-positive extracellular vesicles directly in whole blood, linking their levels to pancreatic cancer ...
A Phase 3 trial found the next-generation KRAS G12C inhibitor divarasib extended median overall survival to 17.7 months versus 12 ...
A new review finds that combining immune-checkpoint inhibitors with locoregional therapies improves progression-free survival in hepatocellular carcinoma, but overall survival ...
A phase II trial reports 11.9-month median overall survival with CIMAvax-EGF plus nivolumab in previously treated advanced NSCLC, with the ...
A meta-analysis of fourteen retrospective cohorts finds that dynamic skeletal muscle deterioration during hepatocellular carcinoma treatment is associated with an ...
A retrospective Eastern Indian cohort study found that children with ALL who had detectable end-of-induction measurable residual disease had significantly ...
A retrospective study of 56 Chinese patients aged 60 and older found PD-1 inhibitor rechallenge after prior immunotherapy produced a ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine